(Q36800680)

16 August 2017

Treatment of deep vein thrombosis with enoxaparin in pediatric cancer patients receiving chemotherapy (English)

1 reference

16 August 2017

1 reference

1 reference

1 reference

Kimo C Stine

1

1 reference

16 August 2017

Robert L Saylors

series ordinal

2

1 reference

16 August 2017

C Suzanne Saccente

series ordinal

3

1 reference

16 August 2017

David L Becton

series ordinal

4

1 reference

16 August 2017

1 April 2007

1 reference

Clinical and Applied Thrombosis-Hemostasis

16 August 2017

1 reference

16 August 2017

13

1 reference

16 August 2017

2

1 reference

16 August 2017

161-165

1 reference

Venous thromboembolic complications in children

16 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1076029606298989

A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029606298989

Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029606298989

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029606298989

Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029606298989

Tissue factor and fibrin in tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029606298989

Low-molecular-weight heparins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029606298989

Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029606298989

Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029606298989

Neonatal symptomatic thromboembolism in Germany: two year survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029606298989

Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029606298989

Managing thromboembolic disease in the cancer patient: efficacy and safety of antithrombotic treatment options in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029606298989

21 January 2018

Identifiers

DOI

10.1177/1076029606298989

1 reference

16 August 2017

1 reference